中國聖牧(01432.HK)因行使認股權證將向中國蒙牛發行11.97億股 中國蒙牛成最大股東
格隆匯7月28日丨中國聖牧(01432.HK)公佈,於2020年7月27日,公司接獲認購方A(中國蒙牛乳業有限公司直接全資附屬公司)的行使通知,認購方A將以每股認股權證股份0.33港元的行使價行使全部11.97億份認股權證A以認購11.97億股認股權證股份,公司確認已於2020年7月28日收到合共3.95億港元認購款項。
根據認股權證A的條款,公司須於2020年7月31日向認購方A配發及發行合共11.97億股認股權證股份,將佔經配發擴大後公司已發行股本約14.53%。於行使上述認股權證A的認購權後,認購方A將無尚未行使的認股權證A的認購權。
緊隨交割後及假設於本公告日期起至交割日期止並無發行公司股份,認購方A將持有合共14.67億股股份,佔已發行股份總數約17.80%,並將成為公司單一最大股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.